AAAAAA
Results:
1-8
|
Results: 8
Authors:
Higenbottam, T
Siddons, T
Citation: T. Higenbottam et T. Siddons, Trials of inhaled Iloprost and other new vasodilating prostaglandins, EUR RESP J, 17(1), 2001, pp. 6-7
Authors:
Higenbottam, T
Siddons, T
Demoncheaux, E
Citation: T. Higenbottam et al., The direct and indirect action of inhaled agents on the lung and its circulation: Lessons for clinical science, ENVIR H PER, 109, 2001, pp. 559-562
Authors:
Maniscalco, M
Sofia, M
Higenbottam, T
Citation: M. Maniscalco et al., Effects of an NO-synthase inhibitor L-NMMA in the hepatopulmonary syndrome, RESPIRATION, 68(2), 2001, pp. 226-226
Authors:
Maniscalco, M
Sofia, M
Carratu, L
Higenbottam, T
Citation: M. Maniscalco et al., Effect of nitric oxide inhibition on nasal airway resistance after nasal allergen challenge in allergic rhinitis, EUR J CL IN, 31(5), 2001, pp. 462-466
Authors:
Higenbottam, T
Siddons, T
Demoncheaux, E
Citation: T. Higenbottam et al., A therapeutic role for chronic inhaled nitric oxide?, LANCET, 356(9228), 2000, pp. 446-447
Authors:
Thomson, JR
Machado, RD
Pauciulo, MW
Morgan, NV
Humbert, M
Elliott, GC
Ward, K
Yacoub, M
Mikhail, G
Rogers, P
Newman, J
Wheeler, L
Higenbottam, T
Gibbs, JSR
Egan, J
Crozier, A
Peacock, A
Allcock, R
Corris, P
Loyd, JE
Trembath, RC
Nichols, WC
Citation: Jr. Thomson et al., Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family, J MED GENET, 37(10), 2000, pp. 741-745
Authors:
Higenbottam, T
Stenmark, K
Simonneau, G
Citation: T. Higenbottam et al., Treatments for severe pulmonary hypertension, LANCET, 353(9150), 1999, pp. 338-340
Authors:
Higenbottam, T
Marriott, H
Cremona, G
Laude, E
Bee, D
Citation: T. Higenbottam et al., The acute effects of dexfenfluramine on human and porcine pulmonary vascular tone and resistance, CHEST, 116(4), 1999, pp. 921-930
Risultati:
1-8
|